 These apparent effects have not been seen at standard doses or in major trials.Researchers have also examined "ultra-low-doses" of naltrexone at microgram, nanogram, and picogram doses, that are co-administered with opioid analgesics with the goal of increasing pain relief and reducing side effects.Organizations promoting low-dose naltrexone have advocated it as a treatment for a variety of medical conditions.